ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

RAPT RAPT Therapeutics Inc

8,30
0,175 (2,15%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
RAPT Therapeutics Inc RAPT NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,175 2,15% 8,30 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
8,28 8,15 8,58 8,33 8,125
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
09.4.202418:00GLOBERAPT Therapeutics Announces Promising Results from Phase 2..
07.3.202422:15EDGAR2Form S-8 - Securities to be offered to employees in employee..
07.3.202414:08EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07.3.202414:03EDGAR2Form 8-K - Current report
07.3.202414:00GLOBERAPT Therapeutics Reports Fourth Quarter and Full Year 2023..
05.3.202422:30GLOBERAPT Therapeutics Announces Multiple Late-Breaking..
22.2.202423:13EDGAR2Form 8-K - Current report
20.2.202422:29EDGAR2Form 8-K - Current report
20.2.202413:30GLOBERAPT Therapeutics Announces Clinical Hold on Studies..
14.2.202414:52EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13.2.202414:00GLOBERAPT Therapeutics Bolsters Leadership Team with the..
31.1.202414:00GLOBERAPT Therapeutics to Participate in the Guggenheim..
02.1.202414:00GLOBERAPT Therapeutics to Present at the 42nd Annual J.P. Morgan..
27.11.202314:00GLOBERAPT Therapeutics Announces Publication of Phase 1a/1b..
13.11.202314:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13.11.202314:03EDGAR2Form 8-K - Current report
13.11.202314:00GLOBERAPT Therapeutics Reports Third Quarter 2023 Financial..
03.11.202317:03EDGAR2Form 8-K - Current report
03.11.202317:00GLOBERAPT Therapeutics Announces Positive Data, Including..
01.11.202321:05GLOBERAPT Therapeutics to Participate in Several Upcoming..
18.10.202315:00GLOBERAPT Therapeutics Announces Two FLX475 Presentations at the..
30.8.202322:05GLOBERAPT Therapeutics to Participate in Several Upcoming..
18.8.202306:15EDGAR2Form EFFECT - Notice of Effectiveness
11.8.202322:02EDGAR2Form 8-K - Current report
11.8.202314:57EDGAR2Form S-3 - Registration statement under Securities Act of..
11.8.202314:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11.8.202314:05EDGAR2Form 8-K - Current report
11.8.202314:00GLOBERAPT Therapeutics Reports Second Quarter 2023 Financial..
07.6.202314:00GLOBERAPT Therapeutics to Participate in the Goldman Sachs Global..
25.5.202323:00GLOBERAPT Therapeutics to Present Biomarker Data Corroborating..
11.5.202314:00GLOBERAPT Therapeutics Reports First Quarter 2023 Financial..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock